留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

六味地黄方通过调节肠道菌群和胆汁酸代谢改善绝经后APOE-/-小鼠的胆固醇代谢异常

张舒睿 冯晗 丁雪 朱瑞功 张启春 李育 孟庆海 卞慧敏

张舒睿, 冯晗, 丁雪, 朱瑞功, 张启春, 李育, 孟庆海, 卞慧敏. 六味地黄方通过调节肠道菌群和胆汁酸代谢改善绝经后APOE-/-小鼠的胆固醇代谢异常[J]. 南京中医药大学学报, 2023, 39(8): 728-737. doi: 10.14148/j.issn.1672-0482.2023.0728
引用本文: 张舒睿, 冯晗, 丁雪, 朱瑞功, 张启春, 李育, 孟庆海, 卞慧敏. 六味地黄方通过调节肠道菌群和胆汁酸代谢改善绝经后APOE-/-小鼠的胆固醇代谢异常[J]. 南京中医药大学学报, 2023, 39(8): 728-737. doi: 10.14148/j.issn.1672-0482.2023.0728
ZHANG Shu-rui, FENG Han, DING Xue, ZHU Rui-gong, ZHANG Qi-chun, LI Yu, MENG Qing-hai, BIAN Hui-min. Liuwei Dihuang Formula Ameliorates Aberrant Cholesterol Metabolism in Postmenopausal APOE-/- Mice by Regulating Intestinal Microbiota and Bile Acid Metabolism[J]. Journal of Nanjing University of traditional Chinese Medicine, 2023, 39(8): 728-737. doi: 10.14148/j.issn.1672-0482.2023.0728
Citation: ZHANG Shu-rui, FENG Han, DING Xue, ZHU Rui-gong, ZHANG Qi-chun, LI Yu, MENG Qing-hai, BIAN Hui-min. Liuwei Dihuang Formula Ameliorates Aberrant Cholesterol Metabolism in Postmenopausal APOE-/- Mice by Regulating Intestinal Microbiota and Bile Acid Metabolism[J]. Journal of Nanjing University of traditional Chinese Medicine, 2023, 39(8): 728-737. doi: 10.14148/j.issn.1672-0482.2023.0728

六味地黄方通过调节肠道菌群和胆汁酸代谢改善绝经后APOE-/-小鼠的胆固醇代谢异常

doi: 10.14148/j.issn.1672-0482.2023.0728
基金项目: 

国家自然科学基金面上项目 81774029

国家自然科学基金面上项目 82274243

国家自然科学基金面上项目 82204382

国家自然科学基金青年科学基金项目 82204382

江苏省高等学校自然科学基金 22KJB310005

详细信息
    作者简介:

    张舒睿, 女, 硕士研究生, E-mail: zsr642202893@163.com

    通讯作者:

    孟庆海, 男, 讲师, 主要从事心血管药理学研究, E-mail: 460189@njucm.edu.cn

    卞慧敏, 女, 研究员, 主要从事心血管药理学研究, E-mail: hmbian@sina.com

  • 中图分类号: R285.5

Liuwei Dihuang Formula Ameliorates Aberrant Cholesterol Metabolism in Postmenopausal APOE-/- Mice by Regulating Intestinal Microbiota and Bile Acid Metabolism

  • 摘要:   目的  探究六味地黄方调节肠道菌群和胆汁酸代谢改善小鼠绝经后胆固醇代谢异常及可能的作用机制。  方法  利用双侧卵巢摘除的APOE-/-小鼠给予高脂饮食, 复制绝经后胆固醇代谢异常模型, 并给予0.13 mg·kg-1的雌二醇和9.0 g·kg-1的六味地黄方进行治疗。90 d治疗结束后, 生化法检测小鼠血清中总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-c)、高密度脂蛋白胆固醇(HDL-c)和肝脏、粪便中TC水平; ELISA法检测小鼠血清肿瘤坏死因子α(TNF-α)、白介素6(IL-6)、白介素1β(IL-1β)水平; 肝脏HE和油红O染色观察小鼠肝脏脂质损伤; 生化法检测小鼠肝脏、血清、胆囊和粪便中总胆汁酸(TBA)含量; 液相质谱联用技术(UPLC-MS)对小鼠肝脏和粪便胆汁酸组分定量分析; 16S rRNA测序分析小鼠结肠菌群, 并分析粪便胆汁酸组分和肠道菌群之间的相关性。  结果  六味地黄方可以降低模型小鼠血清TC、TG、LDL-c以及TNF-α、IL-1β、IL-6水平(P < 0.01), 提高HDL-c水平(P < 0.01);并减少肝脏脂质堆积, 减轻肝脏损伤; 还可降低血清、胆囊和肝脏TBA水平(P < 0.01), 增加粪便中TBA排出(P < 0.01);减少粪便TαMCA、TβMCA、TCA、TCDCA、TDCA和CA结合型胆汁酸的含量(P < 0.05, P < 0.01), 增加次级胆汁酸LCA的含量(P < 0.01)。六味地黄方恢复了模型小鼠结肠菌群的平衡, 上调粪异杆菌属(Allobaculum)的相对丰度(P < 0.01), 并下调颤螺菌属(Oscillospira)和普氏菌(Prevotella)的相对丰度(P < 0.05)。  结论  六味地黄方通过重塑结肠菌群的结构恢复菌群的平衡, 增加粪便中次级胆汁酸的排出以降低血清和肝脏中胆固醇沉积, 从而改善模型小鼠胆固醇代谢异常。

     

  • 图  1  六味地黄方对绝经后APOE-/-小鼠的血清脂质和炎症因子的影响

    注: C57+ND.正常对照组; APOE-/-+OVX+HFD.模型组; APOE-/-+OVX+HFD+E2.雌二醇治疗组; APOE-/-+OVX+HFD+LW.六味地黄方治疗组; 与正常对照组比较, ##P < 0.01;与模型组比较, *P < 0.05, * *P < 0.01。x±s, n=5~6。

    Figure  1.  Effect of LW on serum lipids and inflammatory factors in postmenopausal APOE-/- mice

    图  2  六味地黄方对绝经后APOE-/-小鼠肝脏胆固醇和胆汁酸堆积的影响

    注: A.肝脏HE和油红O染色图,比例尺=50 μm;B.HE染色评价病理损伤面积百分比的定量分析图;C.油红O染色阳性面积百分比的定量分析图; D~E.肝脏TC和TBA含量图;F.肝脏差异胆汁酸含量图; C57+ND.正常对照组; APOE-/-+OVX+HFD.
    模型组; APOE-/-+OVX+HFD+E2.雌二醇治疗组; APOE-/-+OVX+HFD+LW.六味地黄方治疗组; 与正常对照组比较, #P < 0.05, ##P < 0.01;与模型组比较, *P < 0.05, * *P < 0.01。x±s, n=5~6。

    Figure  2.  Effect of LW on hepatic cholesterol and bile acid accumulation in postmenopausal APOE-/- mice

    图  3  六味地黄方对绝经后APOE-/-小鼠的粪便胆固醇和胆汁酸排泄的影响

    注: C57+ND.正常对照组; APOE-/-+OVX+HFD.模型组; APOE-/-+OVX+HFD+E2.雌二醇治疗组; APOE-/-+OVX+HFD+LW.六味地黄方治疗组; 与正常对照组比较, #P < 0.05, ##P < 0.01;与模型组比较, * *P < 0.05, * *P < 0.01。x±s, n=5~6。

    Figure  3.  Effect of LW on fecal cholesterol and bile acid excretion in postmenopausal APOE-/- mice

    图  4  六味地黄方对绝经后APOE-/-小鼠肠道菌群组成的影响

    注: A.物种多样性韦恩图;B.物种多样性PCoA聚类图;C.门水平差异物种丰度图; D.属水平益生菌、致病菌与其他菌组成图;E~H.
    属水平差异物种丰度图。C57+ND.正常对照组; APOE-/-+OVX+HFD.模型组; APOE-/-+OVX+HFD+E2.雌二醇治疗组; APOE-/-+OVX+HFD+LW.六味地黄方治疗组; 与正常对照组比较, ##P < 0.01;与模型组比较, *P < 0.05, * *P < 0.01。x±s, n=5。

    Figure  4.  Effects of LW on intestinal microbial composition in postmenopausal APOE-/- mice

    图  5  粪便胆汁酸组分与肠道菌群相关性分析

    注: 红色表示2类变量之间呈正相关关系; 灰色表示2类变量之间呈负相关关系。
    *表示在0.05级别(双尾)相关性显著; * *表示在0.01级别(双尾)相关性显著。

    Figure  5.  Correlation analysis of fecal bile acids and intestinal microbiota

    图  6  实验机制图

    注: LW.六味地黄方; Prevotella.普氏菌属; Allobaculum.粪异杆菌属

    Figure  6.  Diagram of the experimental mechanism

  • [1] MEHTA LS, VELARDE GP, LEWEY J, et al. Cardiovascular disease risk factors in women: The impact of race and ethnicity: A scientific statement from the American heart association[J]. Circulation, 2023, 147(19): 1471-1487. doi: 10.1161/CIR.0000000000001139
    [2] ROHIRA AD, LONARD DM, O'MALLEY BW. Emerging roles of steroid receptor coactivators in stromal cell responses[J]. J Endocrinol, 2021, 248(2): R41-R50. doi: 10.1530/JOE-20-0511
    [3] SCHWARTZ GN, KAUFMAN PA, GIRIDHAR KV, et al. Alternating 17β-estradiol and aromatase inhibitor therapies is efficacious in postmenopausal women with advanced endocrine-resistant ER+breast cancer[J]. Clin Cancer Res, 2023, 29(15): 2767-2773. doi: 10.1158/1078-0432.CCR-23-0112
    [4] 肖微, 周俊, 章文春. 六味地黄方制剂治疗更年期综合征疗效的Meta分析[J]. 中国实验方剂学杂志, 2016, 22(4): 222-228. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201604051.htm

    XIAO W, ZHOU J, ZHANG WC. Meta-analysis of Liuwei Dihuang prescription in treatment of menopausal syndrome[J]. Chin J Exp Tradit Med Formulae, 2016, 22(4): 222-228. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201604051.htm
    [5] CHEN Q, QI X, FU Y, et al. Liuwei Dihuang formula protect endothelial cells from apoptosis by up-regulating expression of estrogen receptor-α[J]. J Tradit Chin Med Engl Ed, 2021, 41(2): 227-235. http://www.cnki.com.cn/Article/CJFDTotal-ZYYW202102006.htm
    [6] 孟庆海, 马猛华, 余夕潮, 等. 六味地黄方通过上调肠道雌激素受体改善绝经后ApoE-/-小鼠脂代谢异常研究[J]. 南京中医药大学学报, 2020, 36(5): 661-666, 674. http://xb.njucm.edu.cn/article/id/zr20200514

    MENG QH, MA MH, YU XC, et al. Liuwei Dihuang formula alleviates abnormal lipid metabolism by up-regulating intestinal estrogen receptors in postmenopausal ApoE-/- mice[J]. J Nanjing Univ Tradit Chin Med, 2020, 36(5): 661-666, 674. http://xb.njucm.edu.cn/article/id/zr20200514
    [7] DE BOER JF, KUIPERS F, GROEN AK. Cholesterol transport revisited: A new turbo mechanism to drive cholesterol excretion[J]. Trends Endocrinol Metab, 2018, 29(2): 123-133. doi: 10.1016/j.tem.2017.11.006
    [8] SANTOS-MARCOS JA, RANGEL-ZUÑIGA OA, JIMENEZ-LUCENA R, et al. Influence of gender and menopausal status on gut microbiota[J]. Maturitas, 2018, 116: 43-53. doi: 10.1016/j.maturitas.2018.07.008
    [9] 孟庆海. 泽泻醇B乙酸酯通过调节肠道菌群和肠道雌激素受体抗绝经后动脉粥样硬化的机制研究[D]. 南京: 南京中医药大学, 2021.

    MENG QH. Mechanism of alisol B acetate in preventing postmenopausal atherosclerosis by regulating intestinal flora and estrogen receptor[D]. Nanjing: Nanjing University of Chinese Medicine, 2021.
    [10] CHEN Q, ZHANG YH, MENG QH, et al. Liuwei Dihuang prevents postmenopausal atherosclerosis and endothelial cell apoptosis via inhibiting DNMT1-medicated ERα methylation[J]. J Ethnopharmacol, 2020, 252: 112531. doi: 10.1016/j.jep.2019.112531
    [11] 居玲玲, 文红梅, 马昕, 等. 固相萃取HPLC法研究六昧地黄方中马钱素和莫罗苷的血药浓度及配伍变化[J]. 中药新药与临床药理, 2008, 19(3): 206-209. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXY200803016.htm

    JU LL, WEN HM, MA X, et al. Study on loganin and morronside concentrations in rat serum containing Liuwei Dihuang formula by SPE-HPLC and the variety of different combinations[J]. Tradit Chin Drug Res Clin Pharmacol, 2008, 19(3): 206-209. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXY200803016.htm
    [12] 姚远, 吴艳, 马志, 等. 六味地黄方及配伍对去势雌性大鼠动脉粥样硬化模型的作用[J]. 中成药, 2016, 38(10): 2111-2117. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYA201610004.htm

    YAO Y, WU Y, MA Z, et al. Effect of Liuwei Dihuang Formula and its compatibility on rats with ovariectomy-induced atherosclerosis[J]. Chin Tradit Pat Med, 2016, 38(10): 2111-2117. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYA201610004.htm
    [13] ZHENG XJ, CHEN TL, ZHAO AH, et al. Hyocholic acid species as novel biomarkers for metabolic disorders[J]. Nat Commun, 2021, 12(1): 1487. doi: 10.1038/s41467-021-21744-w
    [14] LI MC, WANG SL, LI YT, et al. Gut microbiota-bile acid crosstalk contributes to the rebound weight gain after calorie restriction in mice[J]. Nat Commun, 2022, 13(1): 2060. doi: 10.1038/s41467-022-29589-7
    [15] WOODWARD A, BROOM D, DALTON C, et al. Supervised exercise training and increased physical activity to reduce cardiovascular disease risk in women with polycystic ovary syndrome: Study protocol for a randomized controlled feasibility trial[J]. Trials, 2020, 21(1): 101. doi: 10.1186/s13063-019-3962-7
    [16] MENG QH, MA MH, ZHANG WW, et al. The gut microbiota during the progression of atherosclerosis in the perimenopausal period shows specific compositional changes and significant correlations with circulating lipid metabolites[J]. Gut Microbes, 2021, 13(1): 1-27.
    [17] 马猛华. 基于肠道ERα/IAP/肠道菌群途径探讨六味地黄方抗绝经后动脉粥样硬化作用及机制[D]. 南京: 南京中医药大学, 2021.

    MA MH. Based on the intestinal ERα/IAP/intestinal flora pathway, the anti-atherosclerosis effect and mechanism of Liuwei Dihuang recipe were discussed[D]. Nanjing: Nanjing University of Chinese Medicine, 2021.
    [18] JIA W, XIE GX, JIA WP. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(2): 111-128. doi: 10.1038/nrgastro.2017.119
    [19] 王佩文. 围绝经期冠心病患者总胆汁酸、胆固醇的变化及相关性[D]. 郑州: 郑州大学, 2019.

    WANG PW. Changes and correlation of total bile acids and cholesterol in perimenopausal patients with coronary heart disease[D]. Zhengzhou: Zhengzhou University, 2019.
    [20] ALEMÁN JO, BOKULICH NA, SWANN JR, et al. Fecal microbiota and bile acid interactions with systemic and adipose tissue metabolism in diet-induced weight loss of obese postmenopausal women[J]. J Transl Med, 2018, 16(1): 244. doi: 10.1186/s12967-018-1619-z
    [21] TAYLOR SA, GREEN RM. Bile acids, microbiota, and metabolism[J]. Hepatology, 2018, 68(4): 1229-1231. doi: 10.1002/hep.30078
    [22] QIAO SS, LIU C, SUN L, et al. Gut Parabacteroides merdae protects against cardiovascular damage by enhancing branched-chain amino acid catabolism[J]. Nat Metab, 2022, 4(10): 1271-1286. doi: 10.1038/s42255-022-00649-y
    [23] CHAKAROUN RM, OLSSON LM, BÄCKHED F. The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease[J]. Nat Rev Cardiol, 2023, 20(4): 217-235. doi: 10.1038/s41569-022-00771-0
    [24] ZHAO H, CHEN JJ, LI XP, et al. Compositional and functional features of the female premenopausal and postmenopausal gut microbiota[J]. FEBS Lett, 2019, 593(18): 2655-2664. doi: 10.1002/1873-3468.13527
    [25] DUAN MM, WANG YZ, ZHANG Q, et al. Characteristics of gut microbiota in people with obesity[J]. PLoS One, 2021, 16(8): e0255446. doi: 10.1371/journal.pone.0255446
    [26] FUNABASHI M, GROVE TL, WANG M, et al. A metabolic pathway for bile acid dehydroxylation by the gut microbiome[J]. Nature, 2020, 582(7813): 566-570. doi: 10.1038/s41586-020-2396-4
    [27] MATSON V, CHERVIN CS, GAJEWSKI TF. Cancer and the microbiome-influence of the commensal microbiota on cancer, immune responses, and immunotherapy[J]. Gastroenterology, 2021, 160(2): 600-613.
  • 加载中
图(6)
计量
  • 文章访问数:  308
  • HTML全文浏览量:  39
  • PDF下载量:  42
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-06-15
  • 网络出版日期:  2023-08-17
  • 发布日期:  2023-08-10

目录

    /

    返回文章
    返回